Publication | Closed Access

Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4

CytokineMultiple Sclerosis PatientsAutoimmune DiseaseInterferon-β TreatmentImmune Cell DevelopmentMedicineImmunodeficienciesImmunologyT CellsAutoimmunityHumoral ImmunityT Cell ImmunityCd4 T Cell ResponsesImmunologic DiseaseMultiple SclerosisImmunotherapyNeuroimmunologyImmune Dysregulation